As Walgreens Boots Alliance grapples with a complex and flailing health care strategy, the Deerfield-based pharmacy giant is bringing on a new chief commercial officer with experience at United Health ...

CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...

CVS Health is delving further into medical care, including a rebrand of its health services segment under a new name, “CVS Healthspire.” Under CVS chief executive officer Karen Lynch, the Rhode Island ...

After spending nearly $20 billion to pick up Signify Health and Oak Street Health this year, CVS rebranded its health services business to "CVS Healthspire" as it plots its long-term growth strategy.

Please provide your email address to receive an email when new articles are posted on . CVS Caremark, one of the nation’s largest pharmacy benefit managers, will remove Humira from its major national ...

CVS Health's (NYSE:CVS) investment case looks the most attractive it has in decades, primarily due to three reasons. First, the pharmacy giant is experiencing strong revenue growth, an optimistic ...

The look of the health and wellness products at CVS is about to get a little less prescriptive. The pharmacy chain, which reported $94.59 billion in revenue in the first quarter of 2025, landing ahead ...

CVS Health, the health care company behind the over 9,900 pharmacy stores across the U.S., is investing $15.3 million into a Northside affordable housing development in San Antonio. The company is ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. This article is more than 2 years old. CVS Health reported third quarter ...

WOONSOCKET, R.I., Jan. 15, 2019 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that Walmart has opted to leave the CVS Caremark pharmacy benefit management (PBM) commercial and Managed ...

Trividia Health, Inc., announced today that it's TRUE METRIX(R) Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...